Newronika
Boston, Massachusetts, United States · Artificial Intelligence, Biotechnology, Health Care
Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normal daily activities and improve quality of life.
Key facts
- Headquarters
- Boston, Massachusetts, United States
- Employees
- 22
- Industries
- Artificial Intelligence, Biotechnology, Health Care
- Status
- Private
- Website
- newronika.com
- Company page
Recent activity at Newronika
Newronika funding history
| Date | Round | Amount |
|---|---|---|
| Feb 2025 | Series B | $13.6M |
Leadership
- Michael Fattore, Chief Financial Officer
- Lorenzo Rossi, Chief Executive Officer
- Michael Fattore, Chief Financial Officer
- Lorenzo Rossi, Chief Executive Officer
Verified email and direct lines for Newronika’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Newronika in the news
- Newronika Receives CE Mark for αDBS®, Advancing Its Mission to Make Adaptive Therapy the Standard of Care - PR Newswire (Jul 14, 2026)
- Newronika Announces First Participant Implanted in ADVENT Pivotal Study - PR Newswire (Sep 30, 2026)
- Newronika picks up CE mark for adaptive deep brain stim - MassDevice (Jul 14, 2026)
- Newronika Receives CE Mark Approval for AlphaDBS, Advancing Adaptive Deep Brain Stimulation for Parkinson's Disease - BioSpace (Mar 24, 2025)
- Newronika Closes €13.6 Million Series B Financing to Accelerate Development of Adaptive DBS Platform - Yahoo Finance (Feb 13, 2025)
- Newronika Appoints Keith Carlton as Executive Chairman to Reinforce Strategic Leadership - PR Newswire (Sep 08, 2025)
Companies similar to Newronika
- Shift Bioscience · Artificial Intelligence, Biotechnology, Health Care, Machine Learning, Therapeutics
- Graph Therapeutics · Artificial Intelligence, Biotechnology, Health Care, Machine Learning, Therapeutics
- Change Agents Corporation. · Artificial Intelligence, Biotechnology, Health Care, Machine Learning, Therapeutics
- Pathos AI · Artificial Intelligence, Biotechnology, Health Care, Machine Learning, Therapeutics
- Synaptogenix · Artificial Intelligence, Biotechnology, Health Care, Machine Learning, Therapeutics
About Newronika: questions and answers
What does Newronika do?
Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normal daily activities and improve quality of life.
Where is Newronika headquartered?
Newronika is headquartered in Boston, Massachusetts, United States.
How many employees does Newronika have?
Newronika has about 22 employees.
Has Newronika raised funding?
Yes. Fundz has recorded 1 funding event for Newronika. The most recent, Series B of $13.6M, was in Feb 2025.
Who leads Newronika?
Lorenzo Rossi is a Chief Executive Officer at Newronika.
What is the latest news on Newronika?
On Feb 14, 2025, Fondazione ENEA Tech e Biomedical Leads €13.6 Million Series B Funding Round for Newronika
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy